68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

NCT04483414 PHASE2 WITHDRAWN

The goal of this research is to examine the ability of Gallium-68 (68Ga) Prostate-Specific Membrane Antigen-11 (PSMA-11) positron emission tomography/computed tomography (PET/CT) to detect sites of recurrent prostate cancer in patients with biochemical recurrence previously treated with radical prostatectomy (RP) or external beam radiation (EBRT) and to assess treatment response to subsequent salvage therapy.

Details

Lead sponsor	Dana Mathews
Phase	PHASE2
Status	WITHDRAWN
Start date	Fri Mar 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Prostate Cancer
• Prostate Cancer Metastatic
• Prostate Cancer Metastatic to Bone

Interventions

• 68Ga PSMA-11 injection
• Positron Emission Tomography/Computed Tomography

Countries

United States